Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction

Brain Dev. 2005 Sep;27(6):415-8. doi: 10.1016/j.braindev.2004.11.001. Epub 2004 Dec 15.

Abstract

We investigated basic abnormalities of coagulation and fibrinolysis in Duchenne muscular dystrophy (DMD) patients with cardiac dysfunction. Forty seven patients with DMD, aged 13-37 years old, were enrolled. Based on left ventricular ejection fraction (LVEF) results determined by echocardiography, patients were divided into 3 groups: LVEF less than 30% (markedly depressed group), LVEF between 30 and 50% (slightly depressed), and LVEF greater than 50% (normal). We measured serum levels of total fibrin and fibrinogen degradation products (FDP), as well as plasma fibrinogen, thrombin-antithrombin complex (TAT), prothrombin fragment (F1+2), and D-dimer. The levels of TAT and F1+2 in the markedly depressed group were significantly elevated compared with the other groups, whereas FDP, fibrinogen, and D-dimer levels did not differ among the groups. We concluded that activated coagulation is associated with cardiac dysfunction in patients with DMD.

MeSH terms

  • Adolescent
  • Adult
  • Antithrombin III
  • Blood Coagulation Disorders / blood
  • Blood Coagulation Disorders / complications*
  • Cardiomyopathy, Dilated / blood
  • Cardiomyopathy, Dilated / complications*
  • Cardiomyopathy, Dilated / diagnostic imaging
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / complications*
  • Echocardiography
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Fibrinogen / metabolism
  • Fibrinolysis
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne / blood
  • Muscular Dystrophy, Duchenne / complications*
  • Peptide Fragments / blood
  • Peptide Hydrolases / blood
  • Protein Precursors / blood
  • Prothrombin

Substances

  • Fibrin Fibrinogen Degradation Products
  • Peptide Fragments
  • Protein Precursors
  • antithrombin III-protease complex
  • fibrin fragment D
  • prothrombin fragment 1
  • prothrombin fragment 2
  • Antithrombin III
  • Prothrombin
  • Fibrinogen
  • Peptide Hydrolases